Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

28.60p
   
  • Change Today:
      0.35p
  • 52 Week High: 30.50p
  • 52 Week Low: 14.25p
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 1,237,613
  • Market Cap: £194.59m

ShareCast News

Open Orphan renews contract with Carna Biosciences 01-Feb-2021 ShareCast
Open Orphan confirms first volunteer dosing of n... 11-Jan-2021 ShareCast
Open Orphan renews contract with top-3 pharma cl... 22-Dec-2020 ShareCast
Open Orphan upbeat on progress with nasal Covid-... 14-Dec-2020 ShareCast
Open Orphan secures new two-year contract with G... 30-Oct-2020 ShareCast
Open Orphan to assist UK govt in Covid-19 study 20-Oct-2020 ShareCast
Open Orphan continues talks over coronavirus cha... 16-Oct-2020 ShareCast
Open Orphan subsidiary wins 'important' new cont... 22-Sep-2020 ShareCast
Open Orphan secures study trial contract with my... 10-Aug-2020 ShareCast
Open Orphan signs new pharma trial contract with... 04-Aug-2020 ShareCast
Open Orphan to conduct in-human trials on Covid-... 28-Jul-2020 ShareCast
Open Orphan signs three new contracts with third... 07-Jul-2020 ShareCast
Open Orphan secures major contract with mystery ... 11-Jun-2020 ShareCast
Open Orphan launches Covid antibody testing serv... 04-Jun-2020 ShareCast
Open Orphan confirms details around Covid antibo... 18-May-2020 ShareCast
Open Orphan inks contract with Quotient on Covid... 11-May-2020 ShareCast
Open Orphan signs ?3.5m deal with US biotech firm 04-May-2020 ShareCast
Open Orphan begins testing of Covid-19 anti-vira... 23-Apr-2020 ShareCast
Open Orphan agrees study with European biotech f... 06-Mar-2020 ShareCast
Open Orphan raising at least ?5m for merger with... 31-Jan-2020 ShareCast
Open Orphan inks three-year contract with myster... 06-Jan-2020 ShareCast
Open Orphan signs deal with US biopharmaceutical... 18-Dec-2019 ShareCast
Open Orphan agrees acquisition of hVIVO at 34% p... 09-Dec-2019 ShareCast
Open Orphan signs pharmacology trial contract wi... 18-Nov-2019 ShareCast
Open Orphan inks preferred partner deal with Ips... 11-Nov-2019 ShareCast
Open Orphan signs deal with Empiric Logic to com... 15-Oct-2019 ShareCast
Venn Life Sciences finds 'model client' in Carri... 18-Jan-2019 ShareCast
Venn Life Sciences shuffles board, partners with... 11-Dec-2018 ShareCast
Venn Life Sciences trades in line as it looks to... 15-Feb-2018 ShareCast
Venn Life Sciences revenues edge higher 20-Jul-2017 ShareCast
Venn Life Sciences' share surge after upbeat FY ... 03-Mar-2017 ShareCast
Venn Life Sciences completes £4.74m Innovenn sale 18-Nov-2016 ShareCast
Venn Life Sciences wins new contract worth EUR2.5m 08-Nov-2016 ShareCast
Director dealings: Venn Life Sciences chairman s... 02-Nov-2016 ShareCast
Venn Life Sciences shareholders approve sale of ... 27-Oct-2016 ShareCast
Venn Life Sciences to offload Innovenn UK 04-Oct-2016 ShareCast
Venn Life Sciences shares drop despite revenue r... 28-Sep-2016 ShareCast
Venn Life Sciences wins €2.8m contract 03-Aug-2016 ShareCast
Venn Life Sciences expecting revenues to double 08-Jan-2016 ShareCast
Venn Life Sciences signs EUR1m contract 23-Oct-2015 ShareCast
Venn Life posts narrow interim loss, acquires Ki... 22-Sep-2015 ShareCast
Venn Life Sciences reports strong first-half tra... 13-Aug-2015 ShareCast
Venn Life Sciences appoints new CFO 15-Jun-2015 ShareCast
Venn Life Sciences acquires Cardinal Systems 05-Aug-2014 ShareCast
Venn Life Sciences secures first skin science pa... 19-Jun-2014 ShareCast
Rightmove Chairman sells 7m pounds of shares 27-May-2014 ShareCast
Venn Life Sciences scores multi-million euro con... 16-May-2014 ShareCast
Venn Life Sciences wins new contracts 26-Apr-2013 ShareCast
Venn Life Sciences sets up Russian arm 07-Feb-2013 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 28.60p
Change Today 0.35p
% Change 1.24 %
52 Week High 30.50p
52 Week Low 14.25p
Volume 1,237,613
Shares Issued 680.37m
Market Cap £194.59m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.38% below the market average95.38% below the market average95.38% below the market average95.38% below the market average95.38% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Price Trend
95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average39.29% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 29-Apr-2024

Time Volume / Share Price
16:35 50,000 @ 28.50p
16:35 35,000 @ 28.60p
16:35 22,068 @ 28.60p
16:35 12,932 @ 28.60p
16:24 2,500 @ 28.63p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page